Top compounds associated with response to TAGLN3


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 CCLE pan-cancer AAC -0.014 0.8
mRNA Sorafenib CCLE pan-cancer AAC 0.012 0.8
mRNA TKI258 CCLE pan-cancer AAC -0.012 0.8
mRNA Nilotinib CCLE pan-cancer AAC -0.0055 0.9
mRNA BRD-K09587429 CTRPv2 pan-cancer AAC 0.38 2e-22
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.36 8e-22
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.29 2e-15
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.3 1e-13
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 8e-13
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 2e-12
Download CSV